Our study identified three key biomarkers through the application of bioinformatics strategy and multiple machine learning algorithms, including CTSD, CEBPD and CYP27A1 which capable of predicting the risk of CAD proceeding to AMI in patients with IBD. The gene discussed is CTSD; the disease is inflammatory bowel disease.